NDC 0061-0387 - Otomax
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-0387
- Package NDCs from labels
- 0061-0387-02, 0061-0387-03, 0061-0387-17, 0061-0387-08, 0061-0387-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2026-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Otomax - Merck Sharp & Dohme Corp. | Merck Sharp & Dohme Corp. | 2026-05-18 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-0387-01 | Otomax | 215 g in 1 BOTTLE, PLASTIC | OINTMENT | 215 | 10 | |
| 0061-0387-01 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-02 | Otomax | 7.5 g in 1 TUBE | OINTMENT | 7.5 | 10 | |
| 0061-0387-02 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-03 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-03 | Otomax | 15 g in 1 TUBE | OINTMENT | 15 | 10 | |
| 0061-0387-08 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-08 | Otomax | 30 g in 1 BOTTLE, PLASTIC | OINTMENT | 30 | 10 | |
| 0061-0387-17 | Otomax | 1 in 1 CARTON | OINTMENT | 1 | 10 | |
| 0061-0387-17 | Otomax | 15 g in 1 BOTTLE, DISPENSING | OINTMENT | 15 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Betamethasone valerate | ACTIVE INGREDIENT | 9IFA5XM7R2 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Clotrimazole | ACTIVE INGREDIENT | G07GZ97H65 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Gentamicin Sulfate | ACTIVE INGREDIENT | 8X7386QRLV | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Betamethasone | ACTIVE MOIETY | 9842X06Q6M | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Clotrimazole | ACTIVE MOIETY | G07GZ97H65 | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 | |
| Gentamicin | ACTIVE MOIETY | T6Z9V48IKG | OTOMAX (GENTAMICIN SULFATE, BETAMETHASONE VALERATE, AND CLOTRIMAZOLE) OINTMENT [MERCK SHARP & DOHME CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Micotrin AC | CLOTRIMAZOLE | PureTek Corporation | cbe4dd18-c9ef-a4e4-e053-2995a90a5289 | 2024-10-01 | Warnings | G07GZ97H65 |
| Mycozyl AC | CLOTRIMAZOLE | PureTek Corporation | b676d257-3cfd-7f24-e053-2995a90a546e | 2024-10-01 | Warnings | G07GZ97H65 |
| Clotrimazole 1% | CLOTRIMAZOLE | Dabur India Limited | 22916978-303f-e62a-e063-6394a90a2100 | 2024-09-20 | Warnings | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 4320f2b8-ac47-40f4-9275-e7c5506e30e4 | 2024-09-11 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Actavis Pharma, Inc. | a6ac4020-2c67-426a-8289-7e54ce43d0c9 | 2024-08-27 | Warnings, Adverse reactions | G07GZ97H65 |
| Betamethasone valerate | BETAMETHASONE VALERATE | Alembic Pharmaceuticals Inc. | 3b6fa573-de04-4626-a39a-dca39def6df2 | 2024-08-23 | Adverse reactions | 9IFA5XM7R2 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals, Inc. | 4add8f7b-48f0-6b6a-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | 8X7386QRLV |
| Major Clotrimazole | CLOTRIMAZOLE | NuCare Pharmaceuticals,Inc. | 562dfc9f-1897-330a-e054-00144ff8d46c | 2024-08-14 | Warnings | G07GZ97H65 |
| Publix Athletic Foot | CLOTRIMAZOLE 1% | PUBLIX SUPER MARKETS, INC. | d9f99680-5636-4136-a7c6-c3643339e6b4 | 2024-08-02 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Bausch & Lomb Incorporated | 41d01350-5c4b-42fc-be5f-986ceec02bd3 | 2024-07-22 | Warnings, Adverse reactions | 8X7386QRLV |
| clotrimazole | CLOTRIMAZOLE | NuCare Pharmaceuticals, Inc. | 54241254-1d9a-346a-e054-00144ff8d46c | 2024-07-17 | Warnings | G07GZ97H65 |
| Betamethasone Valerate | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | a2154b33-0f61-49af-e053-2995a90a1810 | 2024-06-20 | Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | NORTHSTAR RX LLC | 8d03b9ba-f7a8-4fbf-9be1-83d815c2be45 | 2024-06-20 | Warnings, Adverse reactions | G07GZ97H65 |
| clotrimazole | CLOTRIMAZOLE | A-S Medication Solutions | b63a3fe5-5684-41bc-ad6c-69c54e5b942d | 2024-06-20 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 82595309-304e-a221-e053-2991aa0ac0a9 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| GENTAMICIN SULFATE | GENTAMICIN SULFATE | NuCare Pharmaceuticals,Inc. | 85424b40-5c2d-421d-e053-2991aa0a7771 | 2024-06-14 | Warnings, Adverse reactions | 8X7386QRLV |
| clotrimazole | CLOTRIMAZOLE | NuCare Pharmaceuticals,Inc. | 627375fb-2f20-16bc-e053-2a91aa0a1542 | 2024-06-06 | Warnings | G07GZ97H65 |
| BETAMETHASONE VALERATE | BETAMETHASONE VALERATE | NuCare Pharmaceuticals,Inc. | 64badc1a-8922-c6e3-e053-2991aa0a8b1c | 2024-06-06 | Adverse reactions | 9IFA5XM7R2 |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | NuCare Pharmaceuticals,Inc. | 5cc511e4-3e7d-70d6-e053-2a91aa0a8044 | 2024-06-04 | Warnings, Adverse reactions | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Cardinal Health 110 dba LEADER | 199df107-3384-6e03-e063-6294a90afc38 | 2024-05-29 | Warnings | G07GZ97H65 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.